Submit Science – Scientific Sessions 2026

2026 Abstract Submission Information

The Hypertrophic Cardiomyopathy Medical Society (HCMS) is continuing to co-locate its annual symposium with #AHA26 in Chicago. To have your research considered for presentation at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions, you must select and submit to an HCMS abstract submission category.

Submissions open from April 8 – June 4, 2026 at 6:00 p.m. CDT/7:00 p.m. EDT:

  • AHA26 General Abstract Submission
  • AHA26 Clinical Case Submission
  • HCMS Abstract Submissions

Abstract Submission Pricing

Late-Breaking Science

Submissions open from June 22 – August 24, 2026 at 6:00 p.m. CDT/7:00 p.m. EDT

  • Late-Breaking Science Submissions
  • Late-Breaking BASIC Science Submissions

2026 Abstract Categories

Basic Science

Abstracts submitted to the following categories will only be considered for presentation at #AHA26. If you would like your abstract to be considered for presentation at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions (HCMS), taking place at #AHA26 on Friday, November 6, you must submit your abstract under an HCMS category.


Cardiac Development, Structure and Function
No. Categories Council
1.01 Cardiac Development BCVS
1.02 Cardiac Hypertrophy, Heart Failure and Ventricular Remodeling BCVS


Genetics and Genomics
No. Categories Council
2.03 Functional Genomics, Transcriptomics, Proteomics, and Metabolomics of Cardiovascular Disease GPM
2.04 Genetic Epidemiology, Genomics, Gene-Based Therapies, Gene Editing, and Pharmacogenomics GPM
2.05 Precision Medicine- Genetic and Genomic Applications GPM


Molecular and Cellular Science
No. Categories Council
3.06 Cardiac Metabolism and Energetics BCVS
3.07 Cardiorenal Physicology/Pathophysiology KCVD
3.08 Cellular Signaling BCVS
3.09 Drug Discovery for Cardiovascular Disease BCVS
3.10 Electrophysiology and Experimental Models of Arrhythmias BCVS
3.11 Gene Expression/Molecular Biology BCVS
3.12 Ischemic Myocardium ATVB


Regenerative Science
No. Categories Council
4.13 Angiogenesis, Vascular Development and Regeneration BCVS
4.14 Cell and Tissue Engineering BCVS
4.15 Differentiation, Remodeling, Extracellular Matrix ATVB
4.16 Protection of Ischemic Myocardium and Myocardial Repair BCVS
4.17 Stem/Progenitor Cells BCVS


Vascular Biology
No. Categories Council
5.18 Atherosclerosis, Hemostasis and Thrombosis and Fibrinolysis ATVB
5.19 Endothelium, Vascular Tone and Nitric Oxide ATVB
5.20 Inflammation and Adhesion Molecules ATVB
5.21 Lipids, Lipid Mediators, and Lipoprotein Metabolism: Cellular and Animal ATVB
5.22 Microcirculation and Cerebral/Coronary/Peripheral Circulation ATVB
Clinical Science

Abstracts submitted to the following categories will only be considered for presentation at #AHA26. If you would like your abstract to be considered for presentation at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions (HCMS), taking place at #AHA26 on Friday, November 6, you must submit your abstract under an HCMS category.


Arrhythmia
No. Categories Council
6.23 Arrhythmia: Clinical Electrophysiology Diagnosis CLCD
6.24 Arrhythmia: Clinical Electrophysiology Risk Stratification CLCD
6.25 Treatment of Arrhythmia: Pharmocologic CLCD
6.26 Treatment of Arrhythmia: Ablation and Surgery CLCD
6.27 Treatment of Arrhythmia: Device Therapy CLCD


Brain Health and Stroke
No. Categories Council
7.28 Brain Health Stroke
7.29 Cerebrovascular Diseases/Stroke (Basic, Clinical and Population) Stroke


Congenital and Pediatric Categories
No. Categories Council
8.30 Adult Congenital Heart Disease Young Hearts
8.31 Pediatric Congenital Heart Defects Young Hearts
8.32 Pediatric Acquired Heart Disease (i.e. infections diseases, other) Young Hearts
8.33 Pediatric Imaging Young Hearts
8.34 Pediatric Electrophysiology Young Hearts
8.35 Pediatric Epidemiology and Population Prevention Young Hearts
8.36 Pediatric Clinical Preventive Cardiovascular Disease Young Hearts
8.37 Pediatric Cardiac Surgery and Intervention Young Hearts
8.38 Pediatric Heart Failure/Transplantation Young Hearts
8.39 Pediatric Critical Care Cardiology Young Hearts


Coronary and Structural Heart
No. Categories Council
9.40 Aortic Valve CLCD
9.41 Catheter-Based Coronary Imaging and Hemodynamics CLCD
9.42 Catheter-Based Coronary Interventions CLCD
9.43 Chronic Coronary Disease CLCD
9.44 Clinical Biomarkers in ACS CLCD
9.45 Coronary Revascularization (percutaneous and/or surgical) CVSA
9.46 Mitral and Tricuspid Valve CVSA
9.47 Pharmacology for PCI CLCD
9.48 Right Ventricular Function and Physiology 3CPR
9.49 Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology CLCD
9.50 Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacologic Therapy CLCD


Critical Care
No. Categories Council
10.51 Critical Care Cardiology 3CPR
10.52 ECMO and Mechanical Assist Support 3CPR


Heart Failure and Cardiomyopathy
No. Categories Council
11.53 Cardio-Oncology CLCD
11.54 End-Stage Heart Failure: Transplantation, Mechanical Circulatory Support, and Medical Therapy CLCD
11.55 Heart Failure and Cardiomyopathies: Diagnosis and Evaluation CLCD
11.56 Heart Failure and Cardiomyopathies: Disease Management CLCD
11.57 Heart Failure and Cardiomyopathies: Pacing and Other Theraputic Devices CLCD
11.58 Heart Failure and Cardiomyopathies: Pathophysiology BCVS
11.59 Heart Failure and Cardiomyopathies: Pharmacologic Therapy CLCD


Hypertension and Nephrology
No. Categories Council
12.60 Hypertension: Basic and Translational HTN
12.61 Hypertension: Clinical HTN
12.62 Nephrology KCVD


Imaging
No. Categories Council
13.63 Computed Tomography (CT): Heart CVRI
13.64 Echocardiography in Clinical Syndromes CLCD
13.65 Echocardiography: Emerging/New Technologies CLCD
13.66 Echocardiography: Evaluation of Systolic and Diastolic Function CLCD
13.67 Magnetic Resonance Imaging (MRI): Heart CVRI
13.68 Non-Coronary Vascular Imaging (CT/MRI/Other) CVRI
13.69 Nuclear Cardiology CLCD


Nursing and Allied Healthcare
No. Categories Council
14.70 Acute and Chronic Care CVSN
14.71 Palliative and End of Life Care CLCD
14.72 Primary Care, Prevention, Education and Disease Management CVSN
14.73 Psychosocial and Behavioral Aspects of Cardiovascular Care CVSN


Pulmonary Hypertension
No. Categories Council
15.74 Pulmonary Hypertension and Diseases Involving Pulmonary Circulation 3CPR


Surgery and Anesthesia
No. Categories Council
16.75 Cardiopulmonary Bypass 3CPR
16.76 Bridge to and Transplantation CVSA
16.77 Heart Failure and Transplantation CVSA
16.78 Intra-Operative CVSA
16.79 Peri-Operative Care CVSA
16.80 Structural Heart: Transcatheter or Surgical Valve Therapy CVSA


Vascular Medicine
No. Categories Council
17.81 Endovascular Therapy PVD
17.82 Thoracic Aortic Disease CVSA
17.83 Vascular Medicine: Basic and Translational PVD
17.84 Vascular Medicine: Clinical Science PVD
17.85 Vascular Medicine: Venous and Thromboembolic Disease PVD
Population Science

Abstracts submitted to the following categories will only be considered for presentation at #AHA26. If you would like your abstract to be considered for presentation at the Hypertrophic Cardiomyopathy Medical Society Sessions (HCMS), taking place at #AHA26 on Friday, November 6, you must submit your abstract under an HCMS category.


Cardiovascular Kidney Metabolic Health
No. Categories Council
18.86 Cardiovascular Kidney and Metabolic Health Lifestyle
18.87 Diabetes Mellitus and CVD: Prevention and Management Lifestyle
18.88 Obesity and Weight Management in CVD Risk and Prevention Lifestyle


Epidemiology, AI, and Bioinformatics
No. Categories Council
19.89 Biomarkers, Risk Assessment and Risk Prediction EPI
19.90 Clinical Trial Design and Research Methodology QCOR
19.91 Health Tech, Artificial Intelligence and Machine Learning QCOR
19.92 Methodology and Data Science EPI
19.93 Population-Based and Observational Studies EPI


Prevention and Lifestyle
No. Categories Council
20.94 Aging and Care of the Older Adult CLCD
20.95 Clinical Lipidology Lifestyle
20.96 Exercise, Physical Activity and Rehabilitation Lifestyle
20.97 LGBTQ+ Health Lifestyle
20.98 Nutrition in CVD Risk and Prevention Lifestyle
20.99 Psychological Health and Wellbeing Stroke
20.100 Sleep Health Lifestyle
20.101 Sports Cardiology and Stress Testing CLCD
20.102 Substance Use and CVD Lifestyle
20.103 Environmental Drivers of Health Lifestyle


Quality and Outcomes Research
No. Categories Council
21.104 Cardiovascular Health Policy QCOR
21.105 Disparities in Health Care Delivery QCOR
21.106 Clinical and Hospital-Based Observational Studies EPI
21.107 Health Disparities and Underrepresented Populations CLCD
21.108 Health Equity and Structural Racism EPI
21.109 Heart Failure and Cardiomyopathies: Quality of Care and Clinical Outcomes CLCD
21.110 Implementation Science EPI
21.111 Quality of Care and Outcomes Research QCOR
21.112 Social Determinants of Health QCOR
21.114 Women's Health and Sex Differences CLCD
Broad Focus
Professional Development
No. Category
22.114 Professional Development, Wellbeing, and Education
(Includes the following: Mentoring Strategies; Innovation in Clinical Education; Teaching/Learning models in Medical Education; Research Career Development, Clinician Psychological Health and Well-Being including burnout.)
Clinical Case

Clinical case reports in cardiovascular medicine provide a mechanism to promote experiential learning about rare conditions, unusual presentations, or novel treatment responses. They also serve as important tools in advancing clinical practice.


Clinical Case Reports
No. Category
23.115 AI in Clinical Decision Making
23.116 Aortic and Vascular Disease
23.117 Behavioral Medicine
23.118 Brain Health, Stroke, and Neuroscience
23.119 Cardio-Oncology
23.120 Congenital Heart Disease and Pediatrics
23.121 Coronary Artery Disease
23.122 Critical Care Cardiology and Anesthesia
23.123 Electrophysiology and Arrhythmias
23.124 Heart Failure and Cardiomyopathies
23.125 Hypertension and Nephrology
22.126 Imaging Innovative Modalities
22.127 Prevention and Cardiovascular Kidney Metabolic Disease
22.128 Pulmonary Hypertension
22.129 Valvular Heart Disease
22.130 Women's Health and Cardio-Obstetrics
HCMS Scientific Sessions at #AHA26

Abstracts for HCMS Scientific Sessions will be submitted via the AHA’s Scientific Sessions 2026 portal, following all AHA processes and deadlines. Abstract submitters will self-select the option to submit to HCMS Scientific Sessions. Abstracts accepted and presented at HCMS Scientific Sessions will be published in the Circulation supplement for AHA’s Scientific Sessions 2026.

HCMS Abstract Submission Categories
Note: These submissions will only be considered for the HCMS Scientific Sessions. If you are interested in submitting an abstract for consideration at #AHA26, you must submit it under an #AHA26 General Abstract Category.

HCMS Abstract Submissions
Number Categories
H.01 HCMS: Basic
H.02 HCMS: Clinical